We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax. SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.07 | -4.54545454545 | 1.54 | 1.72 | 1.4217 | 1469688 | 1.56092947 | CS |
4 | 0.44 | 42.7184466019 | 1.03 | 1.72 | 0.975 | 1462009 | 1.39217462 | CS |
12 | 0.8852 | 151.367989056 | 0.5848 | 1.72 | 0.5595 | 1400092 | 1.1606053 | CS |
26 | 0.57 | 63.3333333333 | 0.9 | 1.72 | 0.4986 | 1188765 | 1.00202719 | CS |
52 | 0.07 | 5 | 1.4 | 1.914 | 0.4986 | 710536 | 1.07030131 | CS |
156 | -6.77 | -82.1601941748 | 8.24 | 15.0789 | 0.4986 | 430333 | 3.18055482 | CS |
260 | 0.55 | 59.7826086957 | 0.92 | 19.38 | 0.11 | 2402048 | 1.97303117 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions